Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tackling Early Morbidity and Mortality in Myeloma (TEAMM)
2011-000366-35Phase 3Completed
- Sponsor
- University of Birmingham
- Start
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of levofloxacin in multiple myeloma (MM), Infection, sponsored by University of Birmingham. Started Aug 2011; status: completed.
02
Drugs
levofloxacin
03
Conditions
multiple myeloma (MM)Infection
Beyond the preview
Go deeper on 2011-000366-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000366-35.